Analyst Ratings For Ionis Pharmaceuticals (NASDAQ:IONS)
Today, Needham & Company LLC reiterated its Buy rating on Ionis Pharmaceuticals (NASDAQ:IONS) with a price target of $64.00.
There are 2 sell ratings, 6 hold ratings, 6 buy ratings on the stock.
The current consensus rating on Ionis Pharmaceuticals (NASDAQ:IONS) is Hold (Score: 2.29) with a consensus target price of $44.00 per share, a potential 19.58% downside.
Some recent analyst ratings include
- 7/26/2017-Needham & Company LLC Reiterated Rating of Buy.
- 7/25/2017-BMO Capital Markets Reiterated Rating of Outperform.
- 7/10/2017-Stifel Nicolaus Reiterated Rating of Hold.
- 5/22/2017-Cowen and Company Reiterated Rating of Market Perform.
- 5/17/2017-Leerink Swann Reiterated Rating of Outperform.
- 3/10/2017-Goldman Sachs Group, Inc. (The) was Downgraded by analysts at Goldman Sachs Group, Inc. (The) from a “Neutral ” rating to a ” Sell” rating. They now have a $25.00 price target on the stock, up previously from $28.00 .
Recent Insider Trading Activity For Ionis Pharmaceuticals (NASDAQ:IONS)
Ionis Pharmaceuticals (NASDAQ:IONS) has insider ownership of 1.86% and institutional ownership of 88.75%.
- On 7/20/2017 Stanley T Crooke, Chairman, sold 11,000 with an average share price of $55.35 per share and the total transaction amounting to $608,850.00. View SEC Filing
- On 7/19/2017 Ionis Pharmaceuticals Inc, Major Shareholder, bought 3,125,000 with an average share price of $8.00 per share and the total transaction amounting to $25,000,000.00. View SEC Filing
- On 7/17/2017 Stanley T Crooke, Chairman, sold 16,500 with an average share price of $52.45 per share and the total transaction amounting to $865,425.00. View SEC Filing
- On 7/3/2017 Brett P Monia, SVP, sold 309 with an average share price of $51.35 per share and the total transaction amounting to $15,867.15. View SEC Filing
- On 7/3/2017 Stanley T Crooke, Chairman, sold 16,500 with an average share price of $52.10 per share and the total transaction amounting to $859,650.00. View SEC Filing
- On 6/1/2017 Patrick R O’neil, SVP, sold 70 with an average share price of $48.00 per share and the total transaction amounting to $3,360.00. View SEC Filing
- On 5/1/2017 Patrick R O’neil, SVP, sold 650 with an average share price of $48.75 per share and the total transaction amounting to $31,687.50. View SEC Filing
Recent Trading Activity for Ionis Pharmaceuticals (NASDAQ:IONS)
Shares of Ionis Pharmaceuticals closed the previous trading session at 55.66 up +0.95 1.74% with 5,231,453 shares trading hands.
